Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model - PubMed (original) (raw)
Affiliations
- PMID: 12789138
Free article
Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model
Samuel J Reich et al. Mol Vis. 2003.
Free article
Abstract
Purpose: RNA interference mediated by small interfering RNAs (siRNAs) is a powerful technology allowing the silencing of mamalian genes with great specificity and potency. The purpose of this study was to demonstrate the feasibility of RNA interference mediated by siRNA in retinal cells in vitro and in the murine retina in vivo.
Methods: siRNAs specific for enhanced green fluorescent protein (EGFP) and murine and human vascular endothelial growth factor (VEGF) were designed. In vitro studies in human cell lines entailed modulation of endogenous VEGF levels through chemically induced hypoxia. Effects of siRNA treatment on these levels were measured by ELISA. In vivo studies evaluating effects of siRNA on levels of EGFP and VEGF were performed by co-injecting recombinant viruses carrying EGFP or hVEGF cDNAs along with the appropriate siRNAs subretinally in mice. Additional studies aimed at blocking production of endogenous mVEGF were performed using laser-induced choroidal neovascularization (CNV) in mice. Effects of in vivo treatments were evaluated ophthalmoscopically. Retinal/choroidal flat mounts were evaluated after perfusion with dextran-fluorescein. Alternatively, retinas were evaluated in histological sections or VEGF levels were measured in intact eyes using ELISA.
Results: Successful delivery of siRNA to the subretinal space was confirmed by observing significantly reduced levels of EGFP in eyes treated with Ad.CMV.EGFP plus EGFP-directed siRNA. siRNAs directed against hVEGF effectively and specifically inhibit hypoxia-induced VEGF levels in human cell lines and after adenoviral induced hVEGF transgene expression in vivo. In addition, subretinal delivery of siRNA directed against murine Vegf significantly inhibited CNV after laser photocoagulation.
Conclusions: Delivery of siRNA can be used in vitro and in vivo to target specific RNAs and to reduce the levels of the specific protein product in the targeted cells. This work suggests that RNA interference has potential for application to studies of retinal biology and for the treatment of a variety of retinal diseases, including those involving abnormal blood vessel growth.
Similar articles
- Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
Ashikari M, Tokoro M, Itaya M, Nozaki M, Ogura Y. Ashikari M, et al. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3820-4. doi: 10.1167/iovs.09-5121. Epub 2010 Feb 3. Invest Ophthalmol Vis Sci. 2010. PMID: 20130283 - Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L, Chen H, Tuo J, Gao X, Chen L. Gu L, et al. Exp Eye Res. 2010 Sep;91(3):433-9. doi: 10.1016/j.exer.2010.06.019. Epub 2010 Jul 1. Exp Eye Res. 2010. PMID: 20599960 - The biology of VEGF and its receptors.
Ferrara N, Gerber HP, LeCouter J. Ferrara N, et al. Nat Med. 2003 Jun;9(6):669-76. doi: 10.1038/nm0603-669. Nat Med. 2003. PMID: 12778165 Review. - Advances in synthetic siRNA delivery.
Manjunath N, Dykxhoorn DM. Manjunath N, et al. Discov Med. 2010 May;9(48):418-30. Discov Med. 2010. PMID: 20515610 Review.
Cited by
- The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice.
Gao Q, Wang W, Lan Y, Chen X, Yang W, Yuan Y, Tan J, Zong Y, Jiang Z. Gao Q, et al. Int J Nanomedicine. 2013;8:1563-72. doi: 10.2147/IJN.S37635. Epub 2013 Apr 19. Int J Nanomedicine. 2013. PMID: 23626468 Free PMC article. - Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle Growth.
Khan T, Weber H, DiMuzio J, Matter A, Dogdas B, Shah T, Thankappan A, Disa J, Jadhav V, Lubbers L, Sepp-Lorenzino L, Strapps WR, Tadin-Strapps M. Khan T, et al. Mol Ther Nucleic Acids. 2016 Aug 2;5(8):e342. doi: 10.1038/mtna.2016.55. Mol Ther Nucleic Acids. 2016. PMID: 27483025 Free PMC article. - Efficacy of Asymmetric siRNA Targeting Androgen Receptors for the Treatment of Androgenetic Alopecia.
Moon IJ, Yoon HK, Kim D, Choi ME, Han SH, Park JH, Hong SW, Cho H, Lee DK, Won CH. Moon IJ, et al. Mol Pharm. 2023 Jan 2;20(1):128-135. doi: 10.1021/acs.molpharmaceut.2c00510. Epub 2022 Nov 9. Mol Pharm. 2023. PMID: 36352823 Free PMC article. - Gene therapy in ophthalmology.
Uthra S, Kumaramanickavel G. Uthra S, et al. Oman J Ophthalmol. 2009 Sep;2(3):108-10. doi: 10.4103/0974-620X.57308. Oman J Ophthalmol. 2009. PMID: 20927205 Free PMC article. - Nonviral delivery of synthetic siRNAs in vivo.
Akhtar S, Benter IF. Akhtar S, et al. J Clin Invest. 2007 Dec;117(12):3623-32. doi: 10.1172/JCI33494. J Clin Invest. 2007. PMID: 18060020 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources